Expression of the Arp2/3 complex in human gliomas and its role in the migration and invasion of glioma cells

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2127-2136

  Liu, Zhifeng ^a   Yang, Xuejun ^b   Chen, Cong ^a   Liu, Bin ^a   Ren, Bingcheng ^a   Wang, Leilei ^a   Zhao, Kai ^a   Yu, Shengping ^b   Ming, Haolang ^b  

^a Tianjin Neurological Institute   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Arp2 3 complex; Glioma; Invasion; Lamellipodia; Migration

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; ANTINEOPLASTIC AGENT; CK 666; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL FUNCTION; CELL INFILTRATION; CELL INVASION; CELL LOSS; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL STRUCTURE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TARGETING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMELLIPODIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; TREATMENT OUTCOME; WOUND HEALING;

ACTIN-RELATED PROTEIN 2-3 COMPLEX; ACTINS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; PSEUDOPODIA;

EID: 84885042956     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2669     Document Type: Article

References (57)

1. Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S and Lee MC: The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31: 494-502, 2011.
2. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30 (Suppl 19): 10-14, 2003.
3. Peterson K: Brain tumors. Neurol Clin 19: 887-902, 2001.
4. Sathornsumetee S and Rich JN: New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 6: 1087-1104, 2006.
5. Sathornsumetee S and Rich JN: Designer therapies for glioblastoma multiforme. Ann NY Acad Sci 1142: 108-132, 2008.
6. Morrell JL, Morphew M and Gould KL: A mutant of Arp2p causes partial disassembly of the Arp2/3 complex and loss of cortical actin function in fission yeast. Mol Biol Cell 10: 4201-4215, 1999.
7. Pollard TD and Cooper JA: Actin, a central player in cell shape and movement. Science 326: 1208-1212, 2009.
8. Liao G, Simone B and Liu G: Mis-localization of Arp2 mRNA impairs persistence of directional cell migration. Exp Cell Res 317: 812-822, 2011.
9. Pollard TD: Regulation of actin filament assembly by Arp2/3 complex and formins. Annu Rev Biophys Biomol Struct 36: 451-477, 2007.
10. Goley ED and Welch MD: The ARP2/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol 7: 713-726, 2006.
11. Cai L, Makhov AM, Schafer DA and Bear JE: Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia. Cell 134: 828-842, 2008.
12. Yokotsuka M, Iwaya K, Saito T, Pandiella A, et al: Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer. Breast Cancer Res Treat 126: 311-318, 2011.
13. Yi K, Unruh JR, Deng M, Slaughter BD, Rubinstein B and Li R: Dynamic maintenance of asymmetric meiotic spindle position through Arp2/3-complex-driven cytoplasmic streaming in mouse oocytes. Nat Cell Biol 13: 1252-1258, 2011.
14. Xiong H, Mohler WA and Soto MC: The branched actin nucleator Arp2/3 promotes nuclear migrations and cell polarity in the C. elegans zygote. Dev Biol 357: 356-369, 2011.
15. Lees-Miller JP, Henry G and Helfman DM: Identification of act2, an essential gene in the fission yeast Schizosaccharomyces pombe that encodes a protein related to actin. Proc Natl Acad Sci USA 89: 80-83, 1992.
16. Winter D, Podtelejnikov AV, Mann M and Li R: The complex containing actin-related proteins Arp2 and Arp3 is required for the motility and integrity of yeast actin patches. Curr Biol 7: 519-529, 1997.
17. Winter DC, Choe EY and Li R: Genetic dissection of the budding yeast Arp2/3 complex: a comparison of the in vivo and structural roles of individual subunits. Proc Natl Acad Sci USA 96: 7288-7293, 1999.
18. Balasubramanian MK, Feoktistova A, McCollum D and Gould KL: Fission yeast Sop2p: a novel and evolutionarily conserved protein that interacts with Arp3p and modulates profilin function. EMBO J 15: 6426-6437, 1996.
19. Sawa M, Suetsugu S, Sugimoto A, Miki H, Yamamoto M and Takenawa T: Essential role of the C. elegans Arp2/3 complex in cell migration during ventral enclosure. J Cell Sci 116: 1505-1518, 2003.
20. Harborth J, Elbashir SM, Bechert K, Tuschl T and Weber K: Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565, 2001.
21. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G and Blenis J: ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell 41: 661-671, 2011.
22. Moreau V, Galan JM, Devilliers G, Haguenauer-Tsapis R and Winsor B: The yeast actin-related protein Arp2p is required for the internalization step of endocytosis. Mol Biol Cell 8: 1361-1375, 1997.
23. Schaerer-Brodbeck C and Riezman H: Functional interactions between the p35 subunit of the Arp2/3 complex and calmodulin in yeast. Mol Biol Cell 11: 1113-1127, 2000.
24. Jonsdottir GA and Li R: Dynamics of yeast Myosin I: evidence for a possible role in scission of endocytic vesicles. Curr Biol 14: 1604-1609, 2004.
25. Benesch S, Polo S, Lai FP, Anderson KI, Stradal TE, Wehland J and Rottner K: N-WASP deficiency impairs EGF internalization and actin assembly at clathrin-coated pits. J Cell Sci 118: 3103-3115, 2005.
26. Laurila E, Savinainen K, Kuuselo R, Karhu R and Kallioniemi A: Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer. Genes Chromosomes Cancer 48: 330-339, 2009.
27. Suraneni P, Rubinstein B, Unruh JR, Durnin M, Hanein D and Li R: The Arp2/3 complex is required for lamellipodia extension and directional fibroblast cell migration. J Cell Biol 197: 239-251, 2012.
28. Mariani L, Beaudry C, McDonough WS, et al: Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53: 161-176, 2001.
29. Imamura H, Takao S and Aikou T: A modified invasion-3-(4,5- dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion. Cancer Res 54: 3620-3624, 1994.
30. Berridge MV and Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482, 1993.
31. Repesh LA: A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9: 192-208, 1989.
32. Wu TL and Zhou D: Viral delivery for gene therapy against cell movement in cancer. Adv Drug Deliv Rev 63: 671-677, 2011.
33. Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med 359: 492-507, 2008.
34. Agudelo-Garcia PA, De Jesus JK, Williams SP, et al: Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia 13: 831-840, 2011.
35. Louis DN: Molecular pathology of malignant gliomas. Annu Rev Pathol 1: 97-117, 2006.
36. Yu SP, Yang XJ, Zhang B, and et al: Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells. Chin Med J (Engl) 124: 2599-2604, 2011.
37. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G and Vecht C: Glioblastoma in adults. Crit Rev Oncol Hematol 67: 139-152, 2008.
38. Stark AM, van de Bergh J, Hedderich J, Mehdorn HM and Nabavi A: Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 114: 840-845, 2012.
39. Lamszus K, Kunkel P and Westphal M: Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 88: 169-177, 2003.
40. Zhai GG, Malhotra R, Delaney M, et al: Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76: 227-237, 2006.
41. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T and Berens ME: Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116: 4409-4417, 2003.
42. Hanisch J, Kolm R, Wozniczka M, Bumann D, Rottner K and Stradal TE: Activation of a RhoA/myosin II-dependent but Arp2/3 complex-independent pathway facilitates Salmonella invasion. Cell Host Microbe 9: 273-285, 2011.
43. Shao D, Levine H and Rappel WJ: Coupling actin flow, adhesion, and morphology in a computational cell motility model. Proc Natl Acad Sci USA 109: 6851-6856, 2012.
44. Insall RH and Machesky LM: Actin dynamics at the leading edge: from simple machinery to complex networks. Dev Cell 17: 310-322, 2009.
45. Campellone KG, Webb NJ, Znameroski EA and Welch MD: WHAMM is an Arp2/3 complex activator that binds microtubules and functions in ER to Golgi transport. Cell 134: 148-161, 2008.
46. Svitkina TM and Borisy GG: Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J Cell Biol 145: 1009-1026, 1999.
47. Vignjevic D and Montagnac G: Reorganisation of the dendritic actin network during cancer cell migration and invasion. Semin Cancer Biol 18: 12-22, 2008.
48. Watanabe N: Inside view of cell locomotion through single-molecule: fast F-/G-actin cycle and G-actin regulation of polymer restoration. Proc Jpn Acad Ser B Phys Biol Sci 86: 62-83, 2010.
49. Mullins RD, Heuser JA and Pollard TD: The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci USA 95: 6181-6186, 1998.
50. Mogilner A and Oster G: Cell motility driven by actin polymerization. Biophys J 71: 3030-3045, 1996.
51. Wu C, Asokan SB, Berginski ME, et al: Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis. Cell 148: 973-987, 2012.
52. Nolen BJ, Tomasevic N, Russell A, et al: Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature 406: 1031-1034, 2009.
53. Li A, Ma Y, Yu X, et al: Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod-driven motility and cell-cycle progression. Dev Cell 21: 722-734, 2011.
54. Verkhovsky AB, Svitkina TM and Borisy GG: Self-polarization and directional motility of cytoplasm. Curr Biol 9: 11-20, 1999.
55. Rottner K and Stradal TE: Actin dynamics and turnover in cell motility. Curr Opin Cell Biol 23: 569-578, 2011.
56. Sibony-Benyamini H and Gil-Henn H: Invadopodia: the leading force. Eur J Cell Biol 91: 896-901, 2012.
57. Yamaguchi H: Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol 91: 902-907, 2012.